Dopamine‑iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.

Dopamine Iron Mitochondrial function Parkinson's disease hiPSC-derived neurons

Journal

Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169

Informations de publication

Date de publication:
20 Apr 2024
Historique:
received: 21 12 2023
revised: 17 04 2024
accepted: 17 04 2024
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 22 4 2024
Statut: aheadofprint

Résumé

Imbalances of iron and dopamine metabolism along with mitochondrial dysfunction have been linked to the pathogenesis of Parkinson's disease (PD). We have previously suggested a direct link between iron homeostasis and dopamine metabolism, as dopamine can increase cellular uptake of iron into macrophages thereby promoting oxidative stress responses. In this study, we investigated the interplay between iron, dopamine, and mitochondrial activity in neuroblastoma SH-SY5Y cells and human induced pluripotent stem cell (hiPSC)-derived dopaminergic neurons differentiated from a healthy control and a PD patient with a mutation in the α-synuclein (SNCA) gene. In SH-SY5Y cells, dopamine treatment resulted in increased expression of the transmembrane iron transporters transferrin receptor 1 (TFR1), ferroportin (FPN), and mitoferrin2 (MFRN2) and intracellular iron accumulation, suggesting that dopamine may promote iron uptake. Furthermore, dopamine supplementation led to reduced mitochondrial fitness including decreased mitochondrial respiration, increased cytochrome c control efficiency, reduced mtDNA copy number and citrate synthase activity, increased oxidative stress and impaired aconitase activity. In dopaminergic neurons derived from a healthy control individual, dopamine showed comparable effects as observed in SH-SY5Y cells. The hiPSC-derived PD neurons harboring an endogenous SNCA mutation demonstrated altered mitochondrial iron homeostasis, reduced mitochondrial capacity along with increased oxidative stress and alterations of tricarboxylic acid cycle linked metabolic pathways compared with control neurons. Importantly, dopamine treatment of PD neurons promoted a rescue effect by increasing mitochondrial respiration, activating antioxidant stress response, and normalizing altered metabolite levels linked to mitochondrial function. These observations provide evidence that dopamine affects iron homeostasis, intracellular stress responses and mitochondrial function in healthy cells, while dopamine supplementation can restore the disturbed regulatory network in PD cells.

Identifiants

pubmed: 38648865
pii: S0969-9961(24)00105-0
doi: 10.1016/j.nbd.2024.106506
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106506

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors declare no competing interests.

Auteurs

Chiara Buoso (C)

Institute for Biomedicine, Eurac Research, 39100 Bolzano, Italy; Department of Internal Medicine II, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Markus Seifert (M)

Department of Internal Medicine II, Medical University of Innsbruck, 6020 Innsbruck, Austria; Christian Doppler Laboratory for Iron Metabolism and Anemia Research, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Martin Lang (M)

Institute for Biomedicine, Eurac Research, 39100 Bolzano, Italy.

Corey M Griffith (CM)

Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 4362 Belvaux, Luxembourg.

Begoña Talavera Andújar (BT)

Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 4362 Belvaux, Luxembourg.

Maria Paulina Castelo Rueda (MPC)

Institute for Biomedicine, Eurac Research, 39100 Bolzano, Italy.

Christine Fischer (C)

Department of Internal Medicine II, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Carolina Doerrier (C)

Oroboros Instruments, 6020 Innsbruck, Austria.

Heribert Talasz (H)

Institute of Medical Biochemistry, Protein Core Facility, Biocenter Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Alessandra Zanon (A)

Institute for Biomedicine, Eurac Research, 39100 Bolzano, Italy.

Peter P Pramstaller (PP)

Institute for Biomedicine, Eurac Research, 39100 Bolzano, Italy.

Emma L Schymanski (EL)

Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 4362 Belvaux, Luxembourg.

Irene Pichler (I)

Institute for Biomedicine, Eurac Research, 39100 Bolzano, Italy. Electronic address: irene.pichler@eurac.edu.

Guenter Weiss (G)

Department of Internal Medicine II, Medical University of Innsbruck, 6020 Innsbruck, Austria; Christian Doppler Laboratory for Iron Metabolism and Anemia Research, Medical University of Innsbruck, 6020 Innsbruck, Austria. Electronic address: Guenter.Weiss@i-med.ac.at.

Classifications MeSH